Wells Fargo & Company Poseida Therapeutics, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 27,833 shares of PSTX stock, worth $70,417. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,833

Previous 24,030 15.83%

Holding current value

$70,417

Previous $76,000 6.58%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$2.0 - $3.46 $7,606 - $13,158	3,803 Added 15.83%	27,833 $81,000
Q1 2024 May 10, 2024	BUY	$2.76 - $4.13 $8,511 - $12,736	3,084 Added 14.72%	24,030 $76,000
Q4 2023 Feb 09, 2024	BUY	$1.83 - $3.51 $7,567 - $14,513	4,135 Added 24.6%	20,946 $70,000
Q3 2023 Nov 13, 2023	SELL	$1.62 - $2.79 $14,531 - $25,026	-8,970 Reduced 34.79%	16,811 $40,000
Q2 2023 Aug 15, 2023	BUY	$1.66 - $3.4 $42,203 - $86,441	25,424 Added 7121.57%	25,781 $45,000
Q1 2023 May 12, 2023	SELL	$3.08 - $8.73 $43,101 - $122,167	-13,994 Reduced 97.51%	357 $1,000
Q4 2022 Feb 13, 2023	BUY	$3.33 - $6.38 $69 - $133	21 Added 0.15%	14,351 $76,000
Q3 2022 Nov 14, 2022	BUY	$2.43 - $4.51 $313 - $581	129 Added 0.91%	14,330 $50,000
Q2 2022 Aug 12, 2022	BUY	$1.87 - $5.0 $140 - $375	75 Added 0.53%	14,201 $37,000
Q1 2022 May 16, 2022	SELL	$3.22 - $7.04 $103,593 - $226,490	-32,172 Reduced 69.49%	14,126 $64,000
Q4 2021 Feb 14, 2022	BUY	$6.23 - $7.6 $287,614 - $350,861	46,166 Added 34974.24%	46,298 $315,000
Q2 2021 Aug 16, 2021	SELL	$7.96 - $10.07 $36,886 - $46,664	-4,634 Reduced 97.23%	132 $1,000
Q1 2021 May 13, 2021	BUY	$8.51 - $11.91 $28,236 - $39,517	3,318 Added 229.14%	4,766 $46,000
Q4 2020 Feb 09, 2021	SELL	$8.29 - $11.7 $22,532 - $31,800	-2,718 Reduced 65.24%	1,448 $16,000
Q3 2020 Nov 05, 2020	BUY	$8.09 - $16.25 $33,702 - $67,697	4,166 New	4,166 $37,000

Others Institutions Holding PSTX

# of Institutions

Shares Held

38.2M

Call Options Held

417K

Put Options Held

42.7K

View Full List

About Poseida Therapeutics, Inc.

Ticker PSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,775,600
Market Cap $217M
Description
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...

More about PSTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Poseida Therapeutics, Inc. Transaction History